Eddie Lau

A review of diffusion-weighted magnetic resonance imaging in head and neck cancer patients for treatment evaluation and prediction of radiation-induced xerostomia.

Tai Ermongkonchai, Richard Khor, Morikatsu Wada, Eddie Lau, Daniel Tao Xing, Sweet Ping Ng

Journal article  |  2023  |  Radiat Oncol

The incidence of head and neck cancers (HNC) is rising worldwide especially with HPV-related oropharynx squamous cell carcinoma. T..

Radiation exposure from radiological procedures in liver transplant candidates with hepatocellular carcinoma.

Numan Kutaiba, Joshua G Varcoe, Peter Barnes, Natalie Succar, Eddie Lau, Kurvi Patwala, Elizabeth Low, Zaid Ardalan, Paul Gow, Mark Goodwin

Journal article  |  2023  |  Eur J Radiol

PURPOSE: Candidates for liver transplantation (LT) with hepatocellular carcinoma (HCC) undergo a large number of diagnostic and in..

PSMA-PET Detection of Unusual Metastases in Castrate-Sensitive Prostate Carcinoma.

Nathanial Harris, Mun Yee Tan, Michael Ng, David Blakey, Mario Guerrieri, Daryl Lim Joon, Eddie Lau, Farshad Foroudi, Alexander Armstrong, Michael Chao

Journal article  |  2023  |  Clin Nucl Med

Prostate cancer (PCa) is a multifaceted, heterogeneous disease (with 7 molecular subtypes), which can metastasize to common sites,..

A pilot study investigating the role of F-18-FDG-PET in the early identification of chemoradiotherapy response in anal cancer

Drew Smith, Daryl Lim Joon, Kellie Knight, Jenny Sim, Michal Schneider, Eddie Lau, Farshad Foroudi, Vincent Khoo

Journal article  |  2022  |  JOURNAL OF MEDICAL RADIATION SCIENCES

INTRODUCTION: Anal cancer (AC) is 18 F-FDG-PET avid and has been used to evaluate treatment response several months after chemorad..

A prospective, multi-centre trial of FET-PET in glioblastoma patients - the TROG 18.06 FIG Study: results of the Nuclear Medicine and Radiation Oncology credentialing program

Eng-Siew Koh, Alisha Moore, Roslyn J Francis, Martin A Ebert, Hui K Gan, Sze T Lee, Eddie Lau, Alana Rossi, Andrew Grose, Sweet P Ng, Elizabeth H Barnes, Bradford A Moffat, Fiona E Scott, Lucas Adda, Farshad Foroudi, Anna K Nowak, Dale L Bailey, Michael Back, Richard De Abreu Lourenco, Andrew M Scott

Conference Proceedings  |  2022  |  WFNOS 2022 Abstract Book

NIMG-49. A PROSPECTIVE, MULTI-CENTRE TRIAL OF FET-PET IN GLIOBLASTOMA PATIENTS - THE TROG 18.06 FIG STUDY: KEY ASPECTS OF IMAGING AND RADIATION ONCOLOGY CREDENTIALING

Eng-Siew Koh, Roslyn J Francis, Martin Ebert, Hui Gan, Sze Ting Lee, Eddie Lau, Alisha Moore, Andrew Grose, Alana Rossi, Sweet Ping Ng, June Yap, Tam Ly, Peter Lin, Mark B Pinkham, Stanley Ngai, Christopher Yu, Peter Gorayski, Hien Le, Ian D Kirkwood, Wilson Vallat, et al.

Journal article  |  2021  |  Neuro-Oncology

Abstract The FIG study is a prospective non-randomised study now recruiting up to 210 newly diagnosed GBM participa..

A PROSPECTIVE, MULTI-CENTRE TRIAL OF FET-PET IN GLIOBLASTOMA PATIENTS - THE TROG 18.06 FIG STUDY: KEY ASPECTS OF IMAGING AND RADIATION ONCOLOGY CREDENTIALING

Eng-Siew Koh, Roslyn J Francis, Martin Ebert, Hui Gan, Sze Ting Lee, Eddie Lau, Alisha Moore, Andrew Grose, Alana Rossi, Sweet Ping Ng, June Yap, Tam Ly, Peter Lin, Mark B Pinkham, Stanley Ngai, Christopher Yu, Peter Gorayski, Hien Le, Ian D Kirkwood, Wilson Vallat, et al.

Conference Proceedings  |  2021  |  NEURO-ONCOLOGY

Phase I safety and bioimaging trial of ifabotuzumab in patients with glioblastoma

A Scott, L Cher, P Inglis, Z Lwin, E Lau, C Wichmann, U Ackermann, A Gunjur, A McDonald, N Coombs, K Remen, N Guo, S Lee, S Gong, J Palmer, K Pathmaraj, G O'Keefe, F Scott, B Day, A Boyd, et al.

Conference Proceedings  |  2021  |  EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A prospective, multi-centre trial of FET PET inGlioblastoma patients - the TROG 18.06 FIG Study

A Scott, R Francis, M Ebert, H Gan, S Lee, E Lau, A Moore, A Grose, E Barnes, B Moffat, F Scott, L Adda, F Foroudi, R De Abreu Lourenco, A Nowak, D Bailey, E Koh

Conference Proceedings  |  2021  |  EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Phase I safety and bioimaging trial of ifabotuzumab in patients with glioblastoma.

Hui K Gan, Lawrence Cher, Po Inglis, Zarnie Lwin, Eddie Lau, Christian Wichmann, Alex McDonald, Ashray Gunjur, Uwe Ackermann, Kirsten Remen, Kate Fluck, Gel Bolarnos, Nancy Guo, Sze Ting Lee, Sylvia Gong, Jodie B Palmer, Kunthi Pathmaraj, Graeme J O'Keefe, Fiona E Scott, Bryan W Day, et al.

Conference Proceedings  |  2021  |  CANCER RESEARCH